Cirrhotic Cardiomyopathy: An Evolving Diagnostic Entity With Long-Term Clinical Sequelae
- PMID: 33683815
- DOI: 10.1002/lt.26046
Cirrhotic Cardiomyopathy: An Evolving Diagnostic Entity With Long-Term Clinical Sequelae
Comment on
-
Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria.Liver Transpl. 2021 Jun;27(6):876-886. doi: 10.1002/lt.26000. Liver Transpl. 2021. PMID: 33533556
References
-
- Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953;32:1025‐1033.
-
- Limas CJ, Guiha NH, Lekagul O, Cohn JN. Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. Circulation 1974;49:754‐760.
-
- Gaskari SA, Honar H, Lee SS. Therapy insight: cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol 2006;3:329‐337.
-
- Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008;57:268‐278.
-
- Izzy M, VanWagner LB, Lin G, Altieri M, Findlay JY, Oh JK, et al. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology 2020;71:334‐345.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical